Skip to content

HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia

HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03158844
Acronym
COLAH
Enrollment
250
Registered
2017-05-18
Start date
2017-05-16
Completion date
2018-05-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Brief summary

The population of inpatients is large in Zambia; however, because of poor linkages between hospitals and community HIV care, there are few data to analyze their engagement in HIV care before and after hospitalization. The goal of the study is to learn more about Zambian adults who are HIV-infected and get hospitalized. The purpose of this study is to gather formative, preliminary data, to be used in future grant applications to improve linkage and engagement in HIV care in Zambia.

Detailed description

The main objective of this study is to generate preliminary data on the outcomes of Zambian HIV-infected individuals after discharge from University Teaching Hospital (UTH) Internal Medicine wards which can inform development of a linkage intervention. Our central hypothesis is that in Sub-Saharan African settings like Zambia hospitalizations among HIV-infected individuals are driven by suboptimal linkage and initiation of ART following HIV diagnosis. Specific Aims: (a) Characterize the distribution of hospitalized 300 HIV-infected adults across the HIV care continuum. (b) Identify structural, psychosocial, clinic, and medical factors that predict suboptimal linkage to care and ART initiation after 90 days of hospital discharge among HIV-infected Zambians.

Interventions

OTHERStandard of care

Routine standard of care per Ministry of Health protocol, including blood draws and examinations.

Sponsors

University Teaching Hospital
CollaboratorUNKNOWN
Centre for Infectious Disease Research in Zambia
CollaboratorOTHER
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * HIV-infected as documented in the UTH file * Admitted to Internal Medicine Ward at UTH

Exclusion criteria

* Unable to provide informed consent * Not planning to remain in Lusaka province for 3 months after discharge

Design outcomes

Primary

MeasureTime frameDescription
Undetectable HIV viral load at 90 days post-discharge90 days after hospital dischargeNumerator is number with HIV RNA \<1000 c/mL tested at 90 days after hospital discharge; denominator is the # enrolled

Secondary

MeasureTime frameDescription
Proportion of HIV-infected inpatients who are on ART upon admissionBaselineNumerator is number who report taking ART up to the time of admission; denominator is the # enrolled
Mortality rate90 days after hospital dischargeMortality from time of enrollment to 90 days after discharge
ART initiationBaseline and 90 days after hospital dischargeProportion not on ART upon admission to hospital who are on ART at 90 days after hospital discharge

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026